9-(1-Methyl-benzimidazol-2-yl)-2,3-5-6-tetrahydro-quinolizino[9,9a,1-gh]coumarin (601506-57-4)

Identification
Name:	9-(1-Methyl-benzimidazol-2-yl)-2,3-5-6-tetrahydro-quinolizino[9,9a,1-gh]coumarin
Synonyms:	9-(1-Methyl-benzimidazol-2-yl)-2,3-5-6-tetrahydro-quinolizino[9,9a,1-gh]coumarin
CAS:	601506-57-4
Molecular Formula:	C23H21N3O2
Molecular Weight:	371.438
Molecular Structure:
Properties
Safety Data

Other Product

2-Propenoic acid,2-methyl-,esters,9- (acetyloxy)-2-(3-furanyl)-3,3a,6,6a,6b,7,8,9,9a,- 10,11a,11b,12,12a-tetradecahydro-5-hydroxy- 1,6b,9a,12a-tetramethyl-12-[(1-oxo-3- phenyl-2-propenyl)oxy]-2H,5H-cyclopent[a]- isobenzofuro[7,1-gh][3]benzoxepin-7-yl ester
9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one,2,3,10,11,12,13-hexahydro-11-hydroxy-10-methoxy-9-methyl-, [9S-(9a,10a,11b,13a)]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(4,8-dimethyl-3,7-nonadienyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-[2R*,5R*,9(E)]]- (9CI)
(9aS)-7,8,9,9a-Tetrahydro-9a-hydroxy-6-methyl-9-(1-methylethenyl)-2-(1-methylethyl)-1H-phenalen-1-one
BIS(2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN-3-YL)CARBONYL
Ethanone,1-[(9R,9aS)-9-(5-acetyl-3-methoxy-2-benzofuranyl)-7,8,9,9a-tetrahydro-9a-methoxy-6,9-dimethyl-2-dibenzofuranyl]-,rel-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,5-dimethyl-5-hexenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-(9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-9-(5-methyl-4-hexenyl)-,[2S-(2R*,5R*)]- (9CI)
2-Butenoic acid,2-methyl-,9-(acetyloxy)-2-(3-furanyl)-3,3a,6,6a,6b,7,8,9,9a,10,11a,11b,12,12a-tetradecahydro-5-hydroxy-1,6b,9a,12a-tetramethyl-12-(1-oxo-3-phenyl-2-propenyl)-2H,5H-cyclopent[a]isobenzofuro[7,1-gh][3]benzoxepin-7-ylester (9CI)
1H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonine-5-methanol,2,3,4,5,6,8-hexahydro-1-methyl-2-(1-methylethyl)-9-octyl-, (2R,5R)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,4,5-trimethylhexyl)-1,2,4,5,6,8-hexahydro-5-(methoxymethyl)-1-methyl-2-(1-methylethyl)-(9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1,1-dimethyl-2-propenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1,1-dimethyl-2-propenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylpropyl)-,[2S-[2R*(R*),5R*]]- (9CI)
2H-Pyran-2-acetic acid,6-[[2-[5-[3-[(3,5-dichloro-2-hydroxy-6-methylbenzoyl)oxy]-1-hydroxy-2-methoxybutyl]tetrahydro-5-methyl-2-furanyl]-9-methoxy-2,4,10-trimethyl-1,6-dioxaspiro[4.5]dec-7-yl]methyl]tetrahydro-a,3,5-trimethyl-, [5R-[5a[2R*[2R*,5S*(1R*,2R*,3S*)],4R*],7b[2R*(R*),3S*,5S*,6S*],9a,10a]]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-(2R*,5S*)]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-hexyl-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-9-octyl-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1R)-1-ethenyl-1,5-dimethyl-4-hexen-1-yl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1S)-1-ethenyl-1,5-dimethyl-4-hexen-1-yl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1S,2S)-2,3-dihydroxy-1-(1H-indol-3-yl)propyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-